We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Itasca Capital Ltd | TSXV:ICL | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.44 | 1.33 | 1.95 | 0 | 00:00:00 |
VANCOUVER, May 6, 2013 /CNW/ -
BULLETIN TYPE: Cease Trade Orders
BULLETIN DATE: May 6, 2013
TSX Venture Companies
A Temporary Cease Trade Orders has been issued by the Ontario Securities Commission on May 6, 2013 against the following companies for failing to file the documents indicated within the required time period:
Symbol | Tier | Company | Failure to File | Period |
Ending | ||||
(Y/M/D) | ||||
ACX | 2 | Acadian Energy Inc. | Audited annual financial statements | |
for the year ended | 12/12/31 | |||
Management's discussion and analysis | ||||
relating to the audited annual financial | ||||
statements for the year ended | 12/12/31 | |||
Certification of the foregoing filings as | ||||
required by National Instrument 52-109 | ||||
Certification of Disclosure in Issuers' | ||||
Annual and Interim Filings. | ||||
GAP | 2 | PharmaGap Inc. | Audited annual financial statements | |
for the year ended | 12/12/31 | |||
Management's discussion and analysis | ||||
relating to the audited annual financial | ||||
statements for the year ended | 12/12/31 | |||
Certification of the foregoing filings as | ||||
required by National Instrument 52-109 | ||||
Certification of Disclosure in Issuers' | ||||
Annual and Interim Filings. | ||||
ICL | 2 | Intellectual Capital Group Ltd. | Audited annual financial statements | |
for the year ended | 12/12/31 | |||
Management's discussion and analysis | ||||
relating to the audited annual financial | ||||
statements for the year ended | 12/12/31 | |||
Certification of the foregoing filings as | ||||
required by National Instrument 52-109 | ||||
Certification of Disclosure in Issuers' | ||||
Annual and Interim Filings. | ||||
MDX | 2 | MedX Health Corp. | Audited annual financial statements | |
for the year ended | 12/12/31 | |||
Management's discussion and analysis | ||||
relating to the audited annual financial | ||||
statements for the year ended | 12/12/31 | |||
Certification of the foregoing filings as | ||||
required by National Instrument 52-109 | ||||
Certification of Disclosure in Issuers' | ||||
Annual and Interim Filings. | ||||
Upon revocation of the Temporary Cease Trade Orders, the companies' shares will remain suspended until the companies meet TSX Venture Exchange requirements. Members are prohibited from trading in the securities of the companies during the period of the suspension or until further notice.
________________________________________
SOURCE TSX Venture Exchange
Copyright 2013 Canada NewsWire
1 Year Itasca Capital Chart |
1 Month Itasca Capital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions